Naučni saradnik
Laboratorija za molekularnu biomedicinu

Institut za molekularnu genetiku i genetičko inženjerstvo (IMGGI),
Univerzitet u Beogradu,

V. Stepe 444a, 11010 Beograd, Srbija
Mob: +381 65 3976445
Tel:  +381 11 3976445
Fax: +381 11 397 58 08
E-mail: vesna.spasovski@imgge.bg.ac.rs                                   

OBRAZOVANJE

2012 - Doktor bioloških nauka, Biološki fakultet (BF), Univerzitet u Beogradu (UB),
(Molekularni mehanizmi patogeneze mijeloproliferativnih neoplazija: poremećaj ekspresije gena uključenih u proliferaciju i apoptozu)
1997 - Diplomirani biolog, BF, UB

ISTRAŽIVAČKO ISKUSTVO

2013 - naučni saradnik, Laboratorija za molekularnu biomedicinu (LMB), IMGGI, UB
2010 - 2013 - istrživač saradnik, LMB, IMGGI, UB
2009 - 2010 - istraživač pripravnik, LMB, IMGGI, UB

RADNO ISKUSTVO

2011 - rukovodilac potprojekta „Retke bolesti u ortopediji: molekularna osnova Pertesove bolesti “ u okviru nacionalnog projekta „Retke bolesti: molekularna patofiziologija, dijagnostički i terapijski modaliteti i socijalni, etički i pravni aspekti“ (MPNTR, III 41004, 2011-2015)
2011 - rukovodilac podprojekta u okviru projekta Noć istraživača, “RENIFEVER” (EU, CSA-SA, FP7-PEOPLE-2011-NIGHT-287432, 2011.)
2009 - 2012 - učesnik u projektu “Mala škola DNKlogije” (MNTRS)
2003 - 2004 - Odsek za medicinsku genetiku, Institut za mentalno zdravlje, Beograd
2002 - 2003 - Laboratorija za citogenetiku i molekularnu genetiku, Klinika za hematologiju, Klinički centar Srbije
2001 - 2002 - Studijski boravak, Laboratorija za neurobiologiju, Max Plank Institut, Minhen         

OBLAST NAUČNOG INTERESOVANJA

Istraživanja u oblasti imunologije u sistemskim, autoimunim i reumatološkim oboljenjima. Istraživanja u oblasti ortopedske genetike, posebno u oblasti osteoimunologije. Implementacija dostignuća iz oblasti regenerativne medicine u istraživački rad, korišćenje terapeutskog potencijala autolognih matičnih ćelija iz masnog tkiva u lečenju zglobova.

ODABRANI NAUČNI RADOVI

Srzentić S, Spasovski V, Spasovski D, Zivković Z, Matanović D, Bascarević Z, Supić ZT, Stojiljković M, Karan-Djurasević T, Stanković B, Pavlović S, Nikcević G, Vukasinović Z. Association of gene variants in TLR4 and IL-6 genes with Perthes disease. Srp Arh Celok Lek. 2014 Jul-Aug;142(7-8):450-6.http://www.ncbi.nlm.nih.gov/pubmed/25233690

Spasovski V, Tosic N, Nikcevic G, Stojiljkovic M, Zukic B, Radmilovic M, Karan-Djurasevic T, Srzentic S, Colovic M, Pavlovic S. The influence of novel transcriptional regulatory element in intron 14 on the expression of Janus kinase 2 gene in myeloproliferative neoplasms. J Appl Genet. 2013 Feb;54(1):21-6 http://www.ncbi.nlm.nih.gov/pubmed/23188718

Jančić I, Arsenović-Ranin N, Sefik-Bukilica M, Zivojinović S, Damjanov N, Spasovski V, Srzentić S, Stanković B, Pavlović S. -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int. 2013 Jun;33(6):1481-6 http://www.ncbi.nlm.nih.gov/pubmed/23233117

Vukasinovic Z, Spasovski D, Kralj-Iglic V, Marinkovic-Eric J, Seslija I, Zivkovic Z, Spasovski V. Impact of triple pelvic osteotomy on contact stress pressure distribution in the hip joint Int Orthop. 2013 Jan;37(1):95-8. http://www.ncbi.nlm.nih.gov/pubmed/23223969

Karan-Djurašević T, Palibrk V, Zukić B, Spasovski V, Glumac I, Čolović M, Čolovic N, Jurisic V, Scorilas A, Pavlović S, Tošić N. Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers. Med Oncol. 2013; 29(1):260-262. http://www.ncbi.nlm.nih.gov/pubmed/23292833

Djordjević M, Klaassen K, Sarajlija A,Tošić N, Zukić B, Kecman B, Ugrin M, Spasovski V, Pavlović S, Stojiljković M. Molecular Genetics and Genotype-Based Estimation of BH4-Responsiveness in Serbian PKU Patients: Spotlight on Phenotypic Implications of p.L48S. J Inh Met Dis Reports. 2012; http://www.ncbi.nlm.nih.gov/pubmed/23430547

Karan-Djurasevic T, Palibrk V, Kostic T, Spasovski V, Nikcevic G, Srzentic S, Colovic M, Colovic N, Vidovic A, Antic D, Mihaljevic B, Pavlovic S, Tosic N. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia. Clinical Lymphoma Myeloma and Leukemia 2012; 12 (4): 252-260. http://www.ncbi.nlm.nih.gov/pubmed/22560084

Kuzmanović M, Tošić N, Čolović N, Karan-Djurašević T, Spasovski V, Radmilović M, Nikčević G, Suvajdzić-Vuković N, Tomin D, Vidović A, Virijević M, Pavlović S, Čolović M. Prognostic Impact of NPM1 Mutations in Serbian Adult Patients with Acute Myeloid Leukemia. Acta Haematol. 2012; 128(4):203-212. http://www.ncbi.nlm.nih.gov/pubmed/22906848

Stojiljković M, Zukić B, Tošić N, Karan-Djurašević T, Spasovski V, Nikčević G, Pavlović S. Novel transcriptional regulatory element in the phenylalanine hydroxylase gene intron. Mol Genet Metab. 2010; 101(1):81-83. http://www.ncbi.nlm.nih.gov/pubmed/20599406

Radmilovic M, Zukic B, Stankovic B, Karan-Djurasevic T, Stojiljkovic M, Spasovski V, Tosic N, Dokmanovic L, Janic D, Pavlovic S. Thalassemia syndromes in Serbia: an update. Hemoglobin 2010; 34(5): 477-85. http://www.ncbi.nlm.nih.gov/pubmed/20854122

Krstovski N, Tošić N, Janić D, Dokmanović L, Kuzmanović M, Spasovski V, Pavlović S.Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature. Med Oncol. 2010; 27(3):640-645. http://www.ncbi.nlm.nih.gov/pubmed/19557552